Drug Approval | March 21, 2022
Alembic Pharmaceuticals receives USFDA approval for Lacosamide tablets
The tablets are indicated for the treatment of partial-onset seizures in patients 4 years of age and older
The tablets are indicated for the treatment of partial-onset seizures in patients 4 years of age and older
Macitentan tablets, 10 mg have an estimated market size of US $ 797 million for twelve months ending Dec 2021 according to IQVIA
Digital meetings driving international partnering at CPhI Japan as companies search for ingredients suppliers
Colchicine tablets are used for the treatment and prevention of gout. It reduces inflammation which causes pain, swelling and other symptoms of gout
The product will be manufactured at Lupin’s facility in Goa, India
Nystatin and Triamcinolone Acetonide ointment is indicated for the treatment of cutaneous candidiasis
The product will be manufactured at Lupin’s facility in Pithampur, India
First of three Amneal biosimilars expected for U.S. approval and launch in 2022
Sevelamer Hydrochloride tablets, 800 mg is a generic equivalent of Renagel tablets, 800 mg
To be marketed by Strides Pharma Inc. in the US market
Subscribe To Our Newsletter & Stay Updated
